• Hepatitis B and C 2025
    Apr 30 2026

    Reviewing screening recommendations and diagnostic evaluation of new outpatient hepatitis B and C cases and general treatment, anticipated side effects and post-treatment monitoring for hepatitis B and C.

    Mostra di più Mostra meno
    29 min
  • PTSD 2026
    Apr 30 2026

    Reviewing updated guidelines for screening, evaluation and treatment of PTSD

    Mostra di più Mostra meno
    21 min
  • Transition from Pediatric to Adult Medicine 2025
    Apr 30 2026

    Reviewing best practices for providers to help support patients in the transition from care with pediatricians for primary care and specialty care to adult medicine

    Mostra di più Mostra meno
    32 min
  • Cannabis 2025
    Apr 30 2026

    Reviewing current evidence, guidelines and laws in Washington state surrounding use of medical cannabis and attestations as well as side effects and harm reduction recommendations for recreational cannabis use

    Mostra di più Mostra meno
    39 min
  • Depression 201 2025
    Mar 8 2026

    Reviewing what to do next in the primary care setting in regard to medication management for depression that is not responding to the first or second SSRI or SNRI trialed.

    Mostra di più Mostra meno
    21 min
  • Fatigue 2025
    Mar 8 2026

    Reviewing a comprehensive approach to fatigue in the primary care setting including evaluation with history, exam and labs, tips on patient communication and expectation setting for evaluation and management as well as diagnosing ME/CFS and treatment recommendations.

    Mostra di più Mostra meno
    33 min
  • Primary Care for Transgender Patients 2025
    Mar 8 2026

    Reviewing the basics of caring for transgender patients in primary care including a review of starting and monitoring gender affirming hormone therapy and guidelines for preventative care screenings

    Mostra di più Mostra meno
    27 min
  • Polymyalgia Rheumatica and Giant Cell Arteritis 2025
    Mar 7 2026

    Reviewing evaluation for polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) in the primary care setting, indications for Rheumatology referral and current recommendations for management, including monitoring for long-term complications and side effects of therapy.

    Mostra di più Mostra meno
    27 min